An analysis of the global expression of microRNAs in an experimental model of physiological left ventricular hypertrophy

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Martinelli, Nidiane C ^a,b,c   Cohen, Carolina R ^a,b,c   Santos, Kátia G ^a,b   Castro, Mauro A ^a   Biolo, Andréia ^a,b   Frick, Luzia ^a   Silvello, Daiane ^a,b   Lopes, Amanda ^a   Schneider, Stéfanie ^a,b   Andrades, Michael E ^a,b   Clausell, Nadine ^a,b   Matte, Ursula ^b,c   Rohde, Luis E ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b Post Graduate Program in Medicine: Medical Sciences   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 143; MICRORNA 150; MICRORNA 26B; MICRORNA 27A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; GENE EXPRESSION REGULATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART WEIGHT; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEDENTARY LIFESTYLE; SIGNAL TRANSDUCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; DNA MICROARRAY; ECHOGRAPHY; GENETICS; METABOLISM; PATHOPHYSIOLOGY; REPRODUCIBILITY;

ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE, INBRED BALB C; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHYSICAL CONDITIONING, ANIMAL; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION;

EID: 84899704081     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093271     Document Type: Article

References (51)

1. Dorn GW 2nd (2007) The fuzzy logic of physiological cardiac hypertrophy. Hypertension 49: 962-970.
2. Pluim BM, Zwinderman AH, van der Laarse A, van der Wall EE (2000) The athlete's heart. A meta-analysis of cardiac structure and function. Circulation 101: 336-344. (Pubitemid 30054163)
3. Barauna VG, Magalhaes FC, Krieger JE, Oliveira EM (2008) AT1 receptor participates in the cardiac hypertrophy induced by resistance training in rats. Am J Physiol Regul Integr Comp Physiol 295: R381-387.
4. Oliveira EM, Sasaki MS, Cerencio M, Barauna VG, Krieger JE (2009) Local renin-angiotensin system regulates left ventricular hypertrophy induced by swimming training independent of circulating renin: a pharmacological study. J Renin Angiotensin Aldosterone Syst 10: 15-23.
5. Oliveira RS, Ferreira JC, Gomes ER, Paixao NA, Rolim NP, et al. (2009) Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice. J Physiol 587: 3899-3910.
6. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
7. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, et al. (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739. (Pubitemid 34455427)
8. Cheng Y, Zhu P, Yang J, Liu X, Dong S, et al. (2010) Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 87: 431-439.
9. Fukushima Y, Nakanishi M, Nonogi H, Goto Y, Iwai N (2011) Assessment of plasma miRNAs in congestive heart failure. Circ J 75: 336-340.
10. Small EM, Olson EN (2011) Pervasive roles of microRNAs in cardiovascular biology. Nature 469: 336-342.
11. Jentzsch C, Leierseder S, Loyer X, Flohrschutz I, Sassi Y, et al. (2012) A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes. J Mol Cell Cardiol 52: 13-20.
12. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, et al. (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. PNAS, USA 103: 18255-18260. (Pubitemid 44871645)
13. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, et al. (2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316: 575-579. (Pubitemid 46683138)
14. Fernandes T, Hashimoto NY, Magalhaes FC, Fernandes FB, Casarini DE, et al. (2011) Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7). Hypertension 58: 182-189.
15. LaPier TL, Swislocki AL, Clark RJ, Rodnick KJ (2001) Voluntary running improves glucose tolerance and insulin resistance in female spontaneously hypertensive rats. Am J Hypertens 14: 708-715. (Pubitemid 32612538)
16. Natali AJ, Turner DL, Harrison SM, White E (2001) Regional effects of voluntary exercise on cell size and contraction-frequency responses in rat cardiac myocytes. J Exp Biol 204: 1191-1199. (Pubitemid 34853567)
17. Foppa M, Duncan BB, Rohde LE (2005) Echocardiography-based left ventricular mass estimation. How should we define hypertrophy? Cardiovascular Ultrasound 3: 17.
18. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A (2011) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57: 833-840.
19. Sourvinou IS, Markou A, Lianidou ES (2013) Quantification of Circulating miRNAs in Plasma: Effect of Preanalytical and Analytical Parameters on Their Isolation and Stability. J Mol Diagn 15: 827-834.
20. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
21. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
22. Huang da W, Sherman BT, RA L (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
23. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
24. Castro MA, Wang X, Fletcher MN, Meyer KB, Markowetz F (2012) RedeR: R/Bioconductor package for representing modular structures, nested networks and multiple levels of hierarchical associations. Genome Biol 13: R29.
25. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
26. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, et al. (2007) Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 42: 1137-1141. (Pubitemid 46829201)
27. Zhu H, Yang Y, Wang Y, Li J, Schiller PW, et al. (2011) MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc Res 92: 75-84.
28. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, et al. (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 103: 18255-18260. (Pubitemid 44871645)
29. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, et al. (2010) Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3: 499-506.
30. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, et al. (2009) A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17: 662-673.
31. Duan X, Ji B, Wang X, Liu J, Zheng Z, et al. (2012) Expression of MicroRNA-1 and MicroRNA-21 in Different Protocols of Ischemic Conditioning in an Isolated Rat Heart Model. Cardiology 122: 36-43.
32. Cheng Y, Liu X, Zhang S, Lin Y, Yang J, et al. (2009) MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 47: 5-14.
33. Patrick DM, Montgomery RL, Qi X, Obad S, Kauppinen S, et al. (2010) Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 120: 3912-3916.
34. Zhang X, Azhar G, Wei JY (2012) The expression of microRNA and microRNA clusters in the aging heart. PLoS One 7: e34688.
35. Bernardo BC, Weeks KL, Pretorius L, McMullen JR (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 128: 191-227.
36. Han M, Yang Z, Sayed D, He M, Gao S, et al. (2012) GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy. Cardiovasc Res 93: 645-654.
37. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100: 416-424.
38. Zhou L, Qi X, Potashkin JA, Abdul-Karim FW, Gorodeski GI (2008) MicroRNAs miR-186 and miR-150 down-regulate expression of the proapoptotic purinergic P2X7 receptor by activation of instability sites at the 39-untranslated region of the gene that decrease steady-state levels of the transcript. J Biol Chem 283: 28274-28286.
39. Cheng AM, Byrom MW, Shelton J, Ford LP (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-1297. (Pubitemid 41439922)
40. Wu Q, Jin H, Yang Z, Luo G, Lu Y, et al. (2010) MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun 392: 340-345.
41. Urbich C, Kaluza D, Fromel T, Knau A, Bennewitz K, et al. (2012) MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood 119: 1607-1616.
42. Lerner M, Lundgren J, Akhoondi S, Jahn A, Ng HF, et al. (2011) MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression. Cell Cycle 10: 2172-2183.
43. Guttilla IK, White BA (2009) Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 284: 23204-23216.
44. Sysa-Shah P, Xu Y, Guo X, Belmonte F, Kang B, et al. (2012) Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice. PLoS One 7: e42805.
45. McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, et al. (2003) Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci U S A 100: 12355-12360. (Pubitemid 37271564)
46. Reiss K, Cheng W, Ferber A, Kajstura J, Li P, et al. (1996) Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci U S A 93: 8630-8635. (Pubitemid 26269611)
47. McMullen JR, Shioi T, Huang WY, Zhang L, Tarnavski O, et al. (2004) The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J Biol Chem 279: 4782-4793. (Pubitemid 38199073)
48. Ying H, Fu H, Rose ML, McCormack AM, Sarathchandra P, et al. (2012) Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110delta prevents chronic rejection of heart allografts. PLoS One 7: e32892.
49. Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE, et al. (2001) The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem 276: 30245-30253.
50. Kerkela R, Kockeritz L, Macaulay K, Zhou J, Doble BW, et al. (2008) Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J Clin Invest 118: 3609-3618.
51. Li X, Kong M, Jiang D, Qian J, Duan Q, et al. (2013) MicroRNA-150 aggravates H2O2-induced cardiac myocyte injury by down-regulating c-myb gene. Acta Biochim Biophys Sin (Shanghai) 45: 734-741.